FFA
GILD icon

First Foundation Advisors’s Gilead Sciences GILD Stock Holding History

First Foundation Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.4M Buy
24,376
+2,347
+11% +$329K 0.14% 102
2025
Q4 		$2.7M Sell
22,029
-395
-2% -$48K 0.1% 118
2025
Q3 		$2.49M Hold
22,424
– – 0.09% 128
2025
Q2 		$2.49M Sell
22,424
-677
-3% -$72K 0.09% 125
2025
Q1 		$2.59M Sell
23,101
-202
-0.9% -$20.8K 0.11% 112
2024
Q4 		$2.15M Sell
23,303
-300
-1% -$27K 0.08% 119
2024
Q3 		$1.98M Buy
23,603
+402
+2% +$30.7K 0.07% 127
2024
Q2 		$1.59M Sell
23,201
-255
-1% -$17K 0.06% 133
2024
Q1 		$1.72M Sell
23,456
-10,690
-31% -$822K 0.07% 131
2023
Q4 		$2.77M Sell
34,146
-15,103
-31% -$1.18M 0.13% 95
2023
Q3 		$3.69M Sell
49,249
-778
-2% -$59.8K 0.17% 84
2023
Q2 		$3.86M Buy
50,027
+937
+2% +$74.7K 0.17% 88
2023
Q1 		$4.07M Sell
49,090
-11,107
-18% -$920K 0.19% 87
2022
Q4 		$5.17M Sell
60,197
-1,766
-3% -$140K 0.25% 76
2022
Q3 		$3.82M Sell
61,963
-295
-0.5% -$18.6K 0.19% 83
2022
Q2 		$3.85M Buy
62,258
+1,879
+3% +$116K 0.17% 86
2022
Q1 		$3.59M Sell
60,379
-4,179
-6% -$267K 0.13% 95
2021
Q4 		$4.69M Buy
64,558
+3,670
+6% +$253K 0.16% 83
2021
Q3 		$4.25M Buy
60,888
+532
+0.9% +$37.4K 0.16% 85
2021
Q2 		$4.16M Buy
60,356
+87
+0.1% +$5.81K 0.16% 88
2021
Q1 		$3.9M Sell
60,269
-533
-0.9% -$34.4K 0.17% 85
2020
Q4 		$3.54M Buy
60,802
+76
+0.1% +$4.59K 0.16% 90
2020
Q3 		$3.84M Sell
60,726
-1,802
-3% -$125K 0.18% 75
2020
Q2 		$4.81M Sell
62,528
-1,262
-2% -$96.7K 0.25% 64
2020
Q1 		$4.77M Buy
63,790
+2,218
+4% +$153K 0.29% 57
2019
Q4 		$4M Buy
61,572
+496
+0.8% +$32.3K 0.2% 82
2019
Q3 		$3.87M Sell
61,076
-618
-1% -$40.4K 0.21% 80
2019
Q2 		$4.17M Sell
61,694
-1,376
-2% -$90.5K 0.23% 78
2019
Q1 		$4.1M Sell
63,070
-95
-0.2% -$6.31K 0.24% 75
2018
Q4 		$3.95M Sell
63,165
-984
-2% -$68.8K 0.25% 71
2018
Q3 		$4.95M Sell
64,149
-1,815
-3% -$137K 0.27% 62
2018
Q2 		$4.67M Buy
65,964
+1,022
+2% +$72.2K 0.27% 56
2018
Q1 		$4.9M Sell
64,942
-2,064
-3% -$164K 0.27% 57
2017
Q4 		$4.8M Sell
67,006
-27,342
-29% -$2.08M 0.26% 65
2017
Q3 		$7.64M Sell
94,348
-13,961
-13% -$1.07M 0.43% 49
2017
Q2 		$7.67M Sell
108,309
-10,057
-8% -$669K 0.45% 47
2017
Q1 		$8.04M Buy
118,366
+5,815
+5% +$409K 0.5% 49
2016
Q4 		$8.06M Sell
112,551
-15,303
-12% -$1.14M 0.53% 50
2016
Q3 		$10.1M Buy
127,854
+24,313
+23% +$1.98M 0.7% 43
2016
Q2 		$8.64M Buy
103,541
+3,103
+3% +$275K 0.62% 46
2016
Q1 		$9.23M Buy
100,438
+32,955
+49% +$2.97M 0.67% 45
2015
Q4 		$6.83M Buy
67,483
+8,664
+15% +$902K 0.47% 58
2015
Q3 		$5.78M Sell
58,819
-899
-2% -$99.8K 0.47% 53
2015
Q2 		$6.99M Sell
59,718
-1,596
-3% -$174K 0.56% 50
2015
Q1 		$6.02M Sell
61,314
-9,936
-14% -$1.01M 0.5% 47
2014
Q4 		$6.72M Buy
71,250
+1,580
+2% +$163K 0.59% 49
2014
Q3 		$7.42M Buy
69,670
+1,788
+3% +$175K 0.74% 42
2014
Q2 		$5.63M Sell
67,882
-26,892
-28% -$2.09M 0.61% 39
2014
Q1 		$6.72M Buy
94,774
+91,645
+2,929% +$7.19M 0.83% 38
2013
Q4 		$235K Buy
+3,129
New +$218K 0.03% 160

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

First Foundation Advisors's GILD Position: Q1 2026 in Review

First Foundation Advisors increased its Gilead Sciences (GILD) stake by 11% in Q1 2026, buying an estimated $329K and bringing the position to 24,376 shares worth $3.4M. The position accounts for 0.14% of the portfolio, ranked #102.

First Foundation Advisors first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $10.1M in Q3 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • First Foundation Advisors held 24,376 shares of Gilead Sciences worth $3.4M as of Q1 2026.
  • First Foundation Advisors bought 2,347 Gilead Sciences shares in Q1 2026, an estimated $329K.
  • Gilead Sciences made up 0.14% of First Foundation Advisors's portfolio in Q1 2026, its #102 holding.
  • First Foundation Advisors first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • First Foundation Advisors's Gilead Sciences position peaked at $10.1M in Q3 2016.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on First Foundation Advisors's 13F filing for Q1 2026, filed 4 May 2026.